Effects of GLP-1 on Forearm Vasodilator Function and Glucose Disposal During Hyperinsulinemia in the Metabolic Syndrome

OBJECTIVE: Patients with the metabolic syndrome (MetS) have impaired insulin-induced enhancement of vasodilator responses. The incretin hormone glucagon-like peptide 1 (GLP-1), beyond its effects on blood glucose, has beneficial actions on vascular function. This study, therefore, aimed to assess wh...

Descripción completa

Detalles Bibliográficos
Autores principales: Tesauro, Manfredi, Schinzari, Francesca, Adamo, Angelo, Rovella, Valentina, Martini, Francesca, Mores, Nadia, Barini, Angela, Pitocco, Dario, Ghirlanda, Giovanni, Lauro, Davide, Campia, Umberto, Cardillo, Carmine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3579378/
https://www.ncbi.nlm.nih.gov/pubmed/23069838
http://dx.doi.org/10.2337/dc12-0763

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3579378/
https://www.ncbi.nlm.nih.gov/pubmed/23069838
http://dx.doi.org/10.2337/dc12-0763

Ejemplares similares